Go back to News
NEWS
Covid-19 | Statement Gómez-Acebo & Pombo
16 March, 2020
At Gómez-Acebo & Pombo we have implemented specific measures to help overcome the situation created by Covid- 19 whilst ensuring the safety of our teams and of those people with whom we may have contact, we have adopted different internal protocols, including teleworking for the whole Firm.
Rest assured that our activity continues to uphold the quality of our service, while contributing with the adopted measures to prevent the spread of the virus.
We are at your disposal at all times, and you can get in touch with your usual contact person or with us by e-mail at comunicacion@ga-p.com or at the following office telephone numbers:
Madrid (+34) 91 582 91 00
Barcelona (+34) 93 415 74 00
Bilbao (+34) 94 415 70 15
Brussels +32 (0) 2 231 12 20
Lisbon (+351) 21 340 86 00
New York (+1) 646 736 3075
London +44 (0)20 7329 5407
Valencia (+34) 96 351 38 35
Vigo (+34) 986 44 33 80
We hope that everything will be back to normal soon.
Rest assured that our activity continues to uphold the quality of our service, while contributing with the adopted measures to prevent the spread of the virus.
We are at your disposal at all times, and you can get in touch with your usual contact person or with us by e-mail at comunicacion@ga-p.com or at the following office telephone numbers:
Madrid (+34) 91 582 91 00
Barcelona (+34) 93 415 74 00
Bilbao (+34) 94 415 70 15
Brussels +32 (0) 2 231 12 20
Lisbon (+351) 21 340 86 00
New York (+1) 646 736 3075
London +44 (0)20 7329 5407
Valencia (+34) 96 351 38 35
Vigo (+34) 986 44 33 80
We hope that everything will be back to normal soon.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
¡NEW! 
PUBLICATION
¡NEW!
On the exclusion of “financial instruments” from consumer protection provisions for the purposes of applicable law
For the purposes of Article 6 of Rome I, the provisions of a contract defining the terms on which a professional receives or executes a CFD-related order are not covered by the exception provided for in Article 6(4)(d).
¡NEW! 
PUBLICATION
¡NEW!
Omnibus VIII package to simplify environmental legislation: measures regarding industrial emissions and environmental impact assessments
The 8th Omnibus Package aims to simplify environmental legislation in order to reduce administrative burdens on businesses. This paper outlines the proposed measures and examines, in particular, the proposed amendments to the Industrial and Livestock Rearing Emissions Directive, as well as the proposal for a regulation on speeding-up environmental assessments.
¡NEW!
PUBLICATION
2 days ago
Public policy considerations in the recognition of foreign arbitral awards settling consumer disputes
Judicial review may extend to the substantive invalidity of the arbitration agreement because it conflicts with mandatory domestic rules — as well as those of the European Union — on consumer protection and, consequently, the concept of public policy encompasses both procedural and substantive public policy.
2 days ago
PUBLICATION
One week ago
Limitation period, extinguishment period, ADR, time window, limitation period, extinguishment period, ADR (a)
Article 7 of Act 1/2025 contains two references to time limits which appear to set out two different rules regarding limitation periods. However, Article 7(3) is not a rule on limitation periods.
One week ago
PUBLICATION
24 Jun, 2026
Invalidity, due to shareholder oppression, of the resolution to file a director liability (to company) claim
The Supreme Court (Judgment no. 824/2026, dated 29 May) affirmed the declaration of invalidity of a company resolution to file a director liability (to company) claim, finding that it had been abusively imposed by the majority insofar as not responding to a reasonable need of the company and having been passed by the majority in its own interest and to the unjustified detriment of the minority.
24 Jun, 2026
PUBLICATION
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
23 Jun, 2026
PUBLICATION
18 Jun, 2026
An insurer may be sued by way of a direct action under Spanish law even if the law governing the insurance contract does not allow such an action
The Supreme Court clarifies the rules governing direct actions in international cases and the limits of the law governing insurance contracts
18 Jun, 2026
PUBLICATION
18 Jun, 2026
Royal Decree 415/2026: key aspects of the new health technology assessment system
Royal Decree 415/2026 establishes a unified framework for the assessment of health technologies in Spain, distinguishing between the technical assessment and the administrative decision regarding funding, pricing or inclusion in the service catalogue, and incorporating the requirements of Regulation (EU) 2021/2282. The aspect that raises the most legal questions in this new piece of legislation is the connection between the assessment regulated by the Royal Decree and the procedures for funding, pricing, and inclusion in the service catalogue.
18 Jun, 2026
PUBLICATION
15 Jun, 2026
Conclusions on the abuse of temporary public sector employment: finding a balance between domestic laws and EU law
15 Jun, 2026